[A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
The results have been compared of the use of two schedules (continuous and cyclic) of multimodality therapy of chronic glomerulonephritis (CGN) including cytostatics, corticosteroids, anticoagulants and deaggregation agents. Continuous therapy was carried out for 12.9 +/- 0.41 months on the average, with the drug dosage being corrected depending on the clinico-laboratory and immunological findings as well as on the parameters of the hemostatic system. Cyclic therapy was conducted for 6 months according to a strictly unified program. It has been shown that continuous individualized treatment compares very favourably with the cyclic schedule, which is particularly marked in mesangiocapillary CGN and CGN with a tubulointerstitial component. It is concluded that continuous multimodality treatment chosen with regard to the clinico-pathogenetic disease characteristics allows CGN prognosis to be improved.
Tov
N L
NL
Sidorova
L D
LD
Valentik
M F
MF
Movchan
E A
EA
Savitskaia
I V
IV
Nekipelova
V I
VI
Dorofeev
S B
SB
Nesina
I A
IA
D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012074:Remission Induction; D013997:Time Factors; D014572:Urology
D000925:Anticoagulants; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D010975:Platelet Aggregation Inhibitors
Kliniko-patogeneticheskiĭ podkhod k vyboru terapevticheskoĭ taktiki pri khronicheskom glomerulonefrite.